nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—CYP3A7—Sorafenib—liver cancer	0.128	0.225	CbGbCtD
Triazolam—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.128	0.225	CbGbCtD
Triazolam—CYP3A5—Sorafenib—liver cancer	0.0962	0.169	CbGbCtD
Triazolam—CYP2C8—Sorafenib—liver cancer	0.0925	0.162	CbGbCtD
Triazolam—CYP2C9—Sorafenib—liver cancer	0.0645	0.113	CbGbCtD
Triazolam—CYP3A4—Sorafenib—liver cancer	0.0375	0.0658	CbGbCtD
Triazolam—CYP3A4—Doxorubicin—liver cancer	0.0228	0.0399	CbGbCtD
Triazolam—Glossodynia—Sorafenib—liver cancer	0.0121	0.0815	CcSEcCtD
Triazolam—Glossitis—Sorafenib—liver cancer	0.00437	0.0295	CcSEcCtD
Triazolam—Clonazepam—NAT2—liver cancer	0.0035	0.442	CrCbGaD
Triazolam—Dysaesthesia—Epirubicin—liver cancer	0.00344	0.0232	CcSEcCtD
Triazolam—Hepatic failure—Sorafenib—liver cancer	0.00325	0.022	CcSEcCtD
Triazolam—Dysaesthesia—Doxorubicin—liver cancer	0.00318	0.0215	CcSEcCtD
Triazolam—Mood swings—Sorafenib—liver cancer	0.00277	0.0187	CcSEcCtD
Triazolam—Redness—Epirubicin—liver cancer	0.0022	0.0149	CcSEcCtD
Triazolam—Stomatitis—Sorafenib—liver cancer	0.00219	0.0148	CcSEcCtD
Triazolam—Jaundice—Sorafenib—liver cancer	0.00219	0.0148	CcSEcCtD
Triazolam—Redness—Doxorubicin—liver cancer	0.00204	0.0138	CcSEcCtD
Triazolam—Tinnitus—Sorafenib—liver cancer	0.00188	0.0127	CcSEcCtD
Triazolam—Erythema—Sorafenib—liver cancer	0.00176	0.0119	CcSEcCtD
Triazolam—Dysgeusia—Sorafenib—liver cancer	0.00172	0.0116	CcSEcCtD
Triazolam—Muscle spasms—Sorafenib—liver cancer	0.00169	0.0114	CcSEcCtD
Triazolam—Thinking abnormal—Epirubicin—liver cancer	0.00162	0.011	CcSEcCtD
Triazolam—Glossitis—Epirubicin—liver cancer	0.00161	0.0109	CcSEcCtD
Triazolam—Syncope—Sorafenib—liver cancer	0.00158	0.0107	CcSEcCtD
Triazolam—Dysarthria—Epirubicin—liver cancer	0.00157	0.0106	CcSEcCtD
Triazolam—Loss of consciousness—Sorafenib—liver cancer	0.00155	0.0104	CcSEcCtD
Triazolam—Hypertension—Sorafenib—liver cancer	0.00152	0.0103	CcSEcCtD
Triazolam—Coordination abnormal—Epirubicin—liver cancer	0.00151	0.0102	CcSEcCtD
Triazolam—Thinking abnormal—Doxorubicin—liver cancer	0.0015	0.0102	CcSEcCtD
Triazolam—Glossitis—Doxorubicin—liver cancer	0.00149	0.0101	CcSEcCtD
Triazolam—Dry mouth—Sorafenib—liver cancer	0.00146	0.0099	CcSEcCtD
Triazolam—Dysarthria—Doxorubicin—liver cancer	0.00145	0.00983	CcSEcCtD
Triazolam—Shock—Sorafenib—liver cancer	0.00141	0.00954	CcSEcCtD
Triazolam—Coordination abnormal—Doxorubicin—liver cancer	0.0014	0.00947	CcSEcCtD
Triazolam—Anorexia—Sorafenib—liver cancer	0.00137	0.00925	CcSEcCtD
Triazolam—Mental disability—Epirubicin—liver cancer	0.00129	0.00872	CcSEcCtD
Triazolam—Dyspnoea—Sorafenib—liver cancer	0.00128	0.00865	CcSEcCtD
Triazolam—Decreased appetite—Sorafenib—liver cancer	0.00125	0.00843	CcSEcCtD
Triazolam—Fatigue—Sorafenib—liver cancer	0.00124	0.00836	CcSEcCtD
Triazolam—Constipation—Sorafenib—liver cancer	0.00123	0.0083	CcSEcCtD
Triazolam—Pain—Sorafenib—liver cancer	0.00123	0.0083	CcSEcCtD
Triazolam—Hepatic failure—Epirubicin—liver cancer	0.0012	0.00812	CcSEcCtD
Triazolam—Mental disability—Doxorubicin—liver cancer	0.00119	0.00807	CcSEcCtD
Triazolam—Gastrointestinal pain—Sorafenib—liver cancer	0.00117	0.00793	CcSEcCtD
Triazolam—Abdominal pain—Sorafenib—liver cancer	0.00113	0.00767	CcSEcCtD
Triazolam—Hepatic failure—Doxorubicin—liver cancer	0.00111	0.00751	CcSEcCtD
Triazolam—Osteoarthritis—Epirubicin—liver cancer	0.00108	0.00729	CcSEcCtD
Triazolam—Affect lability—Epirubicin—liver cancer	0.00106	0.00718	CcSEcCtD
Triazolam—Hypersensitivity—Sorafenib—liver cancer	0.00106	0.00715	CcSEcCtD
Triazolam—Asthenia—Sorafenib—liver cancer	0.00103	0.00696	CcSEcCtD
Triazolam—Mood swings—Epirubicin—liver cancer	0.00102	0.00691	CcSEcCtD
Triazolam—Pruritus—Sorafenib—liver cancer	0.00102	0.00686	CcSEcCtD
Triazolam—Ataxia—Epirubicin—liver cancer	0.00102	0.00686	CcSEcCtD
Triazolam—Clonazepam—CYP2E1—liver cancer	0.00101	0.127	CrCbGaD
Triazolam—Osteoarthritis—Doxorubicin—liver cancer	0.000999	0.00675	CcSEcCtD
Triazolam—Affect lability—Doxorubicin—liver cancer	0.000983	0.00664	CcSEcCtD
Triazolam—Diarrhoea—Sorafenib—liver cancer	0.000982	0.00664	CcSEcCtD
Triazolam—Muscular weakness—Epirubicin—liver cancer	0.000952	0.00643	CcSEcCtD
Triazolam—Dizziness—Sorafenib—liver cancer	0.000949	0.00642	CcSEcCtD
Triazolam—Mood swings—Doxorubicin—liver cancer	0.000946	0.00639	CcSEcCtD
Triazolam—Ataxia—Doxorubicin—liver cancer	0.000939	0.00635	CcSEcCtD
Triazolam—Vomiting—Sorafenib—liver cancer	0.000913	0.00617	CcSEcCtD
Triazolam—Dermatitis—Sorafenib—liver cancer	0.000904	0.00611	CcSEcCtD
Triazolam—Headache—Sorafenib—liver cancer	0.000899	0.00608	CcSEcCtD
Triazolam—Muscular weakness—Doxorubicin—liver cancer	0.000881	0.00595	CcSEcCtD
Triazolam—Dysuria—Epirubicin—liver cancer	0.000872	0.0059	CcSEcCtD
Triazolam—Nausea—Sorafenib—liver cancer	0.000853	0.00576	CcSEcCtD
Triazolam—Drowsiness—Epirubicin—liver cancer	0.000832	0.00562	CcSEcCtD
Triazolam—Stomatitis—Epirubicin—liver cancer	0.000811	0.00548	CcSEcCtD
Triazolam—Jaundice—Epirubicin—liver cancer	0.000811	0.00548	CcSEcCtD
Triazolam—Flunitrazepam—CYP2E1—liver cancer	0.000809	0.102	CrCbGaD
Triazolam—Dysuria—Doxorubicin—liver cancer	0.000807	0.00545	CcSEcCtD
Triazolam—Drowsiness—Doxorubicin—liver cancer	0.00077	0.0052	CcSEcCtD
Triazolam—Jaundice—Doxorubicin—liver cancer	0.00075	0.00507	CcSEcCtD
Triazolam—Stomatitis—Doxorubicin—liver cancer	0.00075	0.00507	CcSEcCtD
Triazolam—Visual impairment—Epirubicin—liver cancer	0.00072	0.00486	CcSEcCtD
Triazolam—Tinnitus—Epirubicin—liver cancer	0.000696	0.0047	CcSEcCtD
Triazolam—Visual impairment—Doxorubicin—liver cancer	0.000666	0.0045	CcSEcCtD
Triazolam—Erythema—Epirubicin—liver cancer	0.00065	0.00439	CcSEcCtD
Triazolam—Flurazepam—CYP2E1—liver cancer	0.000649	0.0819	CrCbGaD
Triazolam—Tinnitus—Doxorubicin—liver cancer	0.000644	0.00435	CcSEcCtD
Triazolam—Flatulence—Epirubicin—liver cancer	0.000641	0.00433	CcSEcCtD
Triazolam—Tension—Epirubicin—liver cancer	0.000638	0.00431	CcSEcCtD
Triazolam—Dysgeusia—Epirubicin—liver cancer	0.000637	0.0043	CcSEcCtD
Triazolam—Nervousness—Epirubicin—liver cancer	0.000631	0.00427	CcSEcCtD
Triazolam—Muscle spasms—Epirubicin—liver cancer	0.000625	0.00422	CcSEcCtD
Triazolam—Ill-defined disorder—Epirubicin—liver cancer	0.000603	0.00408	CcSEcCtD
Triazolam—Midazolam—CYP2E1—liver cancer	0.000602	0.0759	CrCbGaD
Triazolam—Erythema—Doxorubicin—liver cancer	0.000602	0.00406	CcSEcCtD
Triazolam—Agitation—Epirubicin—liver cancer	0.000597	0.00404	CcSEcCtD
Triazolam—Flatulence—Doxorubicin—liver cancer	0.000593	0.00401	CcSEcCtD
Triazolam—Tension—Doxorubicin—liver cancer	0.00059	0.00399	CcSEcCtD
Triazolam—Dysgeusia—Doxorubicin—liver cancer	0.000589	0.00398	CcSEcCtD
Triazolam—Malaise—Epirubicin—liver cancer	0.000586	0.00396	CcSEcCtD
Triazolam—Nervousness—Doxorubicin—liver cancer	0.000584	0.00395	CcSEcCtD
Triazolam—Syncope—Epirubicin—liver cancer	0.000583	0.00394	CcSEcCtD
Triazolam—Muscle spasms—Doxorubicin—liver cancer	0.000578	0.00391	CcSEcCtD
Triazolam—Palpitations—Epirubicin—liver cancer	0.000574	0.00388	CcSEcCtD
Triazolam—Loss of consciousness—Epirubicin—liver cancer	0.000571	0.00386	CcSEcCtD
Triazolam—Hypertension—Epirubicin—liver cancer	0.000561	0.00379	CcSEcCtD
Triazolam—Ill-defined disorder—Doxorubicin—liver cancer	0.000558	0.00377	CcSEcCtD
Triazolam—Clonazepam—ALB—liver cancer	0.000553	0.0698	CrCbGaD
Triazolam—Chest pain—Epirubicin—liver cancer	0.000553	0.00374	CcSEcCtD
Triazolam—Agitation—Doxorubicin—liver cancer	0.000553	0.00374	CcSEcCtD
Triazolam—Anxiety—Epirubicin—liver cancer	0.000552	0.00373	CcSEcCtD
Triazolam—Discomfort—Epirubicin—liver cancer	0.000547	0.0037	CcSEcCtD
Triazolam—Malaise—Doxorubicin—liver cancer	0.000542	0.00367	CcSEcCtD
Triazolam—Dry mouth—Epirubicin—liver cancer	0.000541	0.00366	CcSEcCtD
Triazolam—Syncope—Doxorubicin—liver cancer	0.000539	0.00365	CcSEcCtD
Triazolam—Confusional state—Epirubicin—liver cancer	0.000535	0.00361	CcSEcCtD
Triazolam—Palpitations—Doxorubicin—liver cancer	0.000532	0.00359	CcSEcCtD
Triazolam—Oedema—Epirubicin—liver cancer	0.000531	0.00359	CcSEcCtD
Triazolam—Loss of consciousness—Doxorubicin—liver cancer	0.000529	0.00357	CcSEcCtD
Triazolam—Shock—Epirubicin—liver cancer	0.000522	0.00353	CcSEcCtD
Triazolam—Hypertension—Doxorubicin—liver cancer	0.000519	0.00351	CcSEcCtD
Triazolam—Tachycardia—Epirubicin—liver cancer	0.000518	0.0035	CcSEcCtD
Triazolam—Diazepam—CYP2E1—liver cancer	0.000516	0.0651	CrCbGaD
Triazolam—Hyperhidrosis—Epirubicin—liver cancer	0.000513	0.00347	CcSEcCtD
Triazolam—Chest pain—Doxorubicin—liver cancer	0.000512	0.00346	CcSEcCtD
Triazolam—Anxiety—Doxorubicin—liver cancer	0.00051	0.00345	CcSEcCtD
Triazolam—Discomfort—Doxorubicin—liver cancer	0.000506	0.00342	CcSEcCtD
Triazolam—Anorexia—Epirubicin—liver cancer	0.000506	0.00342	CcSEcCtD
Triazolam—Dry mouth—Doxorubicin—liver cancer	0.000501	0.00338	CcSEcCtD
Triazolam—Confusional state—Doxorubicin—liver cancer	0.000495	0.00334	CcSEcCtD
Triazolam—Oedema—Doxorubicin—liver cancer	0.000491	0.00332	CcSEcCtD
Triazolam—Shock—Doxorubicin—liver cancer	0.000483	0.00326	CcSEcCtD
Triazolam—Insomnia—Epirubicin—liver cancer	0.00048	0.00324	CcSEcCtD
Triazolam—Tachycardia—Doxorubicin—liver cancer	0.000479	0.00324	CcSEcCtD
Triazolam—Paraesthesia—Epirubicin—liver cancer	0.000476	0.00322	CcSEcCtD
Triazolam—Hyperhidrosis—Doxorubicin—liver cancer	0.000475	0.00321	CcSEcCtD
Triazolam—Dyspnoea—Epirubicin—liver cancer	0.000473	0.0032	CcSEcCtD
Triazolam—Somnolence—Epirubicin—liver cancer	0.000472	0.00319	CcSEcCtD
Triazolam—Anorexia—Doxorubicin—liver cancer	0.000468	0.00316	CcSEcCtD
Triazolam—Decreased appetite—Epirubicin—liver cancer	0.000461	0.00312	CcSEcCtD
Triazolam—Fatigue—Epirubicin—liver cancer	0.000457	0.00309	CcSEcCtD
Triazolam—Constipation—Epirubicin—liver cancer	0.000454	0.00307	CcSEcCtD
Triazolam—Pain—Epirubicin—liver cancer	0.000454	0.00307	CcSEcCtD
Triazolam—Insomnia—Doxorubicin—liver cancer	0.000444	0.003	CcSEcCtD
Triazolam—Paraesthesia—Doxorubicin—liver cancer	0.000441	0.00298	CcSEcCtD
Triazolam—Dyspnoea—Doxorubicin—liver cancer	0.000438	0.00296	CcSEcCtD
Triazolam—Feeling abnormal—Epirubicin—liver cancer	0.000437	0.00295	CcSEcCtD
Triazolam—Somnolence—Doxorubicin—liver cancer	0.000436	0.00295	CcSEcCtD
Triazolam—Gastrointestinal pain—Epirubicin—liver cancer	0.000434	0.00293	CcSEcCtD
Triazolam—Decreased appetite—Doxorubicin—liver cancer	0.000427	0.00288	CcSEcCtD
Triazolam—Fatigue—Doxorubicin—liver cancer	0.000423	0.00286	CcSEcCtD
Triazolam—Pain—Doxorubicin—liver cancer	0.00042	0.00284	CcSEcCtD
Triazolam—Constipation—Doxorubicin—liver cancer	0.00042	0.00284	CcSEcCtD
Triazolam—Abdominal pain—Epirubicin—liver cancer	0.000419	0.00283	CcSEcCtD
Triazolam—Feeling abnormal—Doxorubicin—liver cancer	0.000405	0.00273	CcSEcCtD
Triazolam—Gastrointestinal pain—Doxorubicin—liver cancer	0.000401	0.00271	CcSEcCtD
Triazolam—Hypersensitivity—Epirubicin—liver cancer	0.000391	0.00264	CcSEcCtD
Triazolam—Abdominal pain—Doxorubicin—liver cancer	0.000388	0.00262	CcSEcCtD
Triazolam—Asthenia—Epirubicin—liver cancer	0.000381	0.00257	CcSEcCtD
Triazolam—Pruritus—Epirubicin—liver cancer	0.000375	0.00254	CcSEcCtD
Triazolam—Diarrhoea—Epirubicin—liver cancer	0.000363	0.00245	CcSEcCtD
Triazolam—Hypersensitivity—Doxorubicin—liver cancer	0.000362	0.00244	CcSEcCtD
Triazolam—Asthenia—Doxorubicin—liver cancer	0.000352	0.00238	CcSEcCtD
Triazolam—Dizziness—Epirubicin—liver cancer	0.000351	0.00237	CcSEcCtD
Triazolam—Pruritus—Doxorubicin—liver cancer	0.000347	0.00235	CcSEcCtD
Triazolam—Vomiting—Epirubicin—liver cancer	0.000337	0.00228	CcSEcCtD
Triazolam—Diarrhoea—Doxorubicin—liver cancer	0.000336	0.00227	CcSEcCtD
Triazolam—Dermatitis—Epirubicin—liver cancer	0.000334	0.00226	CcSEcCtD
Triazolam—Headache—Epirubicin—liver cancer	0.000332	0.00225	CcSEcCtD
Triazolam—Dizziness—Doxorubicin—liver cancer	0.000325	0.00219	CcSEcCtD
Triazolam—Nausea—Epirubicin—liver cancer	0.000315	0.00213	CcSEcCtD
Triazolam—Vomiting—Doxorubicin—liver cancer	0.000312	0.00211	CcSEcCtD
Triazolam—Dermatitis—Doxorubicin—liver cancer	0.000309	0.00209	CcSEcCtD
Triazolam—Headache—Doxorubicin—liver cancer	0.000308	0.00208	CcSEcCtD
Triazolam—Nausea—Doxorubicin—liver cancer	0.000292	0.00197	CcSEcCtD
Triazolam—Diazepam—ALB—liver cancer	0.000283	0.0358	CrCbGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	9.37e-05	0.000342	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	9.22e-05	0.000337	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—RAF1—liver cancer	9.22e-05	0.000336	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CPT1B—liver cancer	9.2e-05	0.000336	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GLUL—liver cancer	9.2e-05	0.000336	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—HRAS—liver cancer	9.17e-05	0.000335	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—HRAS—liver cancer	9.16e-05	0.000334	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—HRAS—liver cancer	9.16e-05	0.000334	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	9.13e-05	0.000333	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—HRAS—liver cancer	9.06e-05	0.000331	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—PPARA—liver cancer	8.96e-05	0.000327	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—RAF1—liver cancer	8.94e-05	0.000326	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—RAF1—liver cancer	8.94e-05	0.000326	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—EPT1—liver cancer	8.94e-05	0.000326	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NR1H4—liver cancer	8.87e-05	0.000324	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—AKT1—liver cancer	8.86e-05	0.000323	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	8.81e-05	0.000322	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—PPARA—liver cancer	8.8e-05	0.000321	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTA3—liver cancer	8.72e-05	0.000318	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GGT1—liver cancer	8.72e-05	0.000318	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—PPARA—liver cancer	8.65e-05	0.000316	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—PPARA—liver cancer	8.59e-05	0.000314	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TAT—liver cancer	8.47e-05	0.000309	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	8.43e-05	0.000308	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.33e-05	0.000304	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	8.29e-05	0.000302	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ALB—liver cancer	8.14e-05	0.000297	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—HRAS—liver cancer	8.05e-05	0.000294	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ALB—liver cancer	8.02e-05	0.000293	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTA4—liver cancer	7.98e-05	0.000291	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—HRAS—liver cancer	7.9e-05	0.000288	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.83e-05	0.000286	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTA2—liver cancer	7.77e-05	0.000284	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—HRAS—liver cancer	7.77e-05	0.000284	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	7.76e-05	0.000283	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—UGDH—liver cancer	7.74e-05	0.000282	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	7.73e-05	0.000282	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.72e-05	0.000282	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—HRAS—liver cancer	7.72e-05	0.000282	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ALB—liver cancer	7.59e-05	0.000277	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	7.58e-05	0.000277	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—HRAS—liver cancer	7.54e-05	0.000275	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTA1—liver cancer	7.5e-05	0.000274	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ALB—liver cancer	7.49e-05	0.000274	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—HRAS—liver cancer	7.43e-05	0.000271	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—NAT2—liver cancer	7.41e-05	0.000271	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	7.37e-05	0.000269	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—RAF1—liver cancer	7.36e-05	0.000269	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—EPT1—liver cancer	7.27e-05	0.000265	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—RAF1—liver cancer	7.25e-05	0.000265	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTM1—liver cancer	7.2e-05	0.000263	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALDOB—liver cancer	7.11e-05	0.000259	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	7.1e-05	0.000259	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—HRAS—liver cancer	7.03e-05	0.000257	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—HRAS—liver cancer	6.94e-05	0.000253	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TAT—liver cancer	6.9e-05	0.000252	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—RAF1—liver cancer	6.86e-05	0.000251	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	6.85e-05	0.00025	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.82e-05	0.000249	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	6.78e-05	0.000248	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CRABP1—liver cancer	6.78e-05	0.000248	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—RAF1—liver cancer	6.78e-05	0.000247	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.73e-05	0.000246	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ALB—liver cancer	6.66e-05	0.000243	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CPT1B—liver cancer	6.65e-05	0.000243	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GLUL—liver cancer	6.65e-05	0.000243	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	6.62e-05	0.000242	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ALB—liver cancer	6.54e-05	0.000239	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ALB—liver cancer	6.43e-05	0.000235	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NR1H4—liver cancer	6.41e-05	0.000234	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ALB—liver cancer	6.38e-05	0.000233	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—HRAS—liver cancer	6.35e-05	0.000232	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA3—liver cancer	6.3e-05	0.00023	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	6.27e-05	0.000229	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.24e-05	0.000228	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	6.2e-05	0.000226	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—HRAS—liver cancer	6.17e-05	0.000225	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—HRAS—liver cancer	6.06e-05	0.000221	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—RAF1—liver cancer	6.02e-05	0.00022	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—HRAS—liver cancer	5.95e-05	0.000217	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HPGDS—liver cancer	5.93e-05	0.000216	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—RAF1—liver cancer	5.91e-05	0.000216	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—HRAS—liver cancer	5.91e-05	0.000216	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—RAF1—liver cancer	5.81e-05	0.000212	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—HRAS—liver cancer	5.81e-05	0.000212	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—RAF1—liver cancer	5.77e-05	0.000211	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA4—liver cancer	5.77e-05	0.00021	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CPT1B—liver cancer	5.76e-05	0.00021	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GLUL—liver cancer	5.76e-05	0.00021	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	5.67e-05	0.000207	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA2—liver cancer	5.62e-05	0.000205	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NR1H4—liver cancer	5.55e-05	0.000203	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	5.48e-05	0.0002	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA3—liver cancer	5.46e-05	0.000199	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTA1—liver cancer	5.42e-05	0.000198	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—NAT2—liver cancer	5.36e-05	0.000196	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PSMA4—liver cancer	5.28e-05	0.000193	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PSMD10—liver cancer	5.28e-05	0.000193	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GOT2—liver cancer	5.14e-05	0.000188	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALDOB—liver cancer	5.14e-05	0.000188	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—UGDH—liver cancer	5.1e-05	0.000186	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.08e-05	0.000185	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—HRAS—liver cancer	5.08e-05	0.000185	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA4—liver cancer	4.99e-05	0.000182	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	4.96e-05	0.000181	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CRABP1—liver cancer	4.9e-05	0.000179	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.88e-05	0.000178	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA2—liver cancer	4.87e-05	0.000178	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP2E1—liver cancer	4.83e-05	0.000176	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—EPT1—liver cancer	4.8e-05	0.000175	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTA1—liver cancer	4.7e-05	0.000171	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CPT1B—liver cancer	4.69e-05	0.000171	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GLUL—liver cancer	4.69e-05	0.000171	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—NAT2—liver cancer	4.64e-05	0.000169	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TAT—liver cancer	4.55e-05	0.000166	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYCS—liver cancer	4.52e-05	0.000165	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NR1H4—liver cancer	4.52e-05	0.000165	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.46e-05	0.000163	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALDOB—liver cancer	4.45e-05	0.000162	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA3—liver cancer	4.44e-05	0.000162	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GGT1—liver cancer	4.44e-05	0.000162	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GOT1—liver cancer	4.44e-05	0.000162	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HPGDS—liver cancer	4.28e-05	0.000156	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CRABP1—liver cancer	4.25e-05	0.000155	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA4—liver cancer	4.06e-05	0.000148	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—liver cancer	3.99e-05	0.000145	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.97e-05	0.000145	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA2—liver cancer	3.96e-05	0.000145	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—HMOX1—liver cancer	3.93e-05	0.000143	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.82e-05	0.00014	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTA1—liver cancer	3.82e-05	0.000139	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSMD10—liver cancer	3.82e-05	0.000139	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PSMA4—liver cancer	3.82e-05	0.000139	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—NAT2—liver cancer	3.78e-05	0.000138	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GOT2—liver cancer	3.72e-05	0.000136	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HPGDS—liver cancer	3.71e-05	0.000135	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.69e-05	0.000135	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTM1—liver cancer	3.66e-05	0.000134	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.63e-05	0.000133	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALDOB—liver cancer	3.62e-05	0.000132	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP2E1—liver cancer	3.49e-05	0.000127	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CYP1A1—liver cancer	3.47e-05	0.000127	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CRABP1—liver cancer	3.46e-05	0.000126	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.36e-05	0.000123	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.32e-05	0.000121	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSMA4—liver cancer	3.31e-05	0.000121	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PSMD10—liver cancer	3.31e-05	0.000121	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYCS—liver cancer	3.27e-05	0.000119	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—MTHFR—liver cancer	3.24e-05	0.000118	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GOT2—liver cancer	3.22e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GGT1—liver cancer	3.21e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GOT1—liver cancer	3.21e-05	0.000117	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARA—liver cancer	3.18e-05	0.000116	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.11e-05	0.000114	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CPT1B—liver cancer	3.09e-05	0.000113	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GLUL—liver cancer	3.09e-05	0.000113	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP2E1—liver cancer	3.03e-05	0.00011	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HPGDS—liver cancer	3.02e-05	0.00011	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3e-05	0.00011	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NR1H4—liver cancer	2.98e-05	0.000109	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA3—liver cancer	2.93e-05	0.000107	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.93e-05	0.000107	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—liver cancer	2.88e-05	0.000105	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—HMOX1—liver cancer	2.84e-05	0.000104	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYCS—liver cancer	2.83e-05	0.000103	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GOT1—liver cancer	2.78e-05	0.000101	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GGT1—liver cancer	2.78e-05	0.000101	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.74e-05	9.98e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CG—liver cancer	2.72e-05	9.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.7e-05	9.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSMD10—liver cancer	2.69e-05	9.83e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PSMA4—liver cancer	2.69e-05	9.83e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA4—liver cancer	2.68e-05	9.78e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTM1—liver cancer	2.65e-05	9.66e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PPARG—liver cancer	2.62e-05	9.58e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GOT2—liver cancer	2.62e-05	9.56e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA2—liver cancer	2.61e-05	9.53e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTA1—liver cancer	2.52e-05	9.2e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CYP1A1—liver cancer	2.51e-05	9.16e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—liver cancer	2.5e-05	9.11e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—NAT2—liver cancer	2.49e-05	9.09e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP2E1—liver cancer	2.46e-05	8.99e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—HMOX1—liver cancer	2.46e-05	8.98e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CD—liver cancer	2.39e-05	8.73e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALDOB—liver cancer	2.39e-05	8.72e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.38e-05	8.7e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ALB—liver cancer	2.36e-05	8.61e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—MTHFR—liver cancer	2.34e-05	8.54e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYCS—liver cancer	2.3e-05	8.41e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARA—liver cancer	2.3e-05	8.38e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTM1—liver cancer	2.29e-05	8.37e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CRABP1—liver cancer	2.28e-05	8.32e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GGT1—liver cancer	2.26e-05	8.25e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GOT1—liver cancer	2.26e-05	8.25e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CYP1A1—liver cancer	2.17e-05	7.93e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CB—liver cancer	2.08e-05	7.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—liver cancer	2.03e-05	7.41e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—MTHFR—liver cancer	2.03e-05	7.4e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—HMOX1—liver cancer	2e-05	7.31e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HPGDS—liver cancer	1.99e-05	7.27e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARA—liver cancer	1.99e-05	7.26e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CG—liver cancer	1.97e-05	7.17e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PPARG—liver cancer	1.9e-05	6.92e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTM1—liver cancer	1.87e-05	6.81e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.79e-05	6.52e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSMD10—liver cancer	1.78e-05	6.48e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PSMA4—liver cancer	1.78e-05	6.48e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CYP1A1—liver cancer	1.77e-05	6.46e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CD—liver cancer	1.73e-05	6.31e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GOT2—liver cancer	1.73e-05	6.3e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ALB—liver cancer	1.71e-05	6.23e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CG—liver cancer	1.7e-05	6.21e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—MTHFR—liver cancer	1.65e-05	6.02e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PPARG—liver cancer	1.64e-05	6e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP2E1—liver cancer	1.62e-05	5.93e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARA—liver cancer	1.62e-05	5.91e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYCS—liver cancer	1.52e-05	5.55e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CB—liver cancer	1.51e-05	5.5e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CD—liver cancer	1.5e-05	5.46e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GGT1—liver cancer	1.49e-05	5.44e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GOT1—liver cancer	1.49e-05	5.44e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ALB—liver cancer	1.48e-05	5.39e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.45e-05	5.3e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CG—liver cancer	1.39e-05	5.06e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—liver cancer	1.34e-05	4.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PPARG—liver cancer	1.34e-05	4.88e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—HMOX1—liver cancer	1.32e-05	4.82e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CB—liver cancer	1.3e-05	4.76e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PIK3CA—liver cancer	1.27e-05	4.64e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTM1—liver cancer	1.23e-05	4.49e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CD—liver cancer	1.22e-05	4.45e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ALB—liver cancer	1.2e-05	4.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CYP1A1—liver cancer	1.17e-05	4.26e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—MTHFR—liver cancer	1.09e-05	3.97e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARA—liver cancer	1.07e-05	3.89e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CB—liver cancer	1.06e-05	3.88e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AKT1—liver cancer	1.04e-05	3.79e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PIK3CA—liver cancer	9.18e-06	3.35e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CG—liver cancer	9.14e-06	3.34e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PPARG—liver cancer	8.82e-06	3.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CD—liver cancer	8.03e-06	2.93e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PIK3CA—liver cancer	7.95e-06	2.9e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ALB—liver cancer	7.93e-06	2.89e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AKT1—liver cancer	7.5e-06	2.74e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CB—liver cancer	7e-06	2.56e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AKT1—liver cancer	6.5e-06	2.37e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PIK3CA—liver cancer	6.47e-06	2.36e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AKT1—liver cancer	5.29e-06	1.93e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PIK3CA—liver cancer	4.27e-06	1.56e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AKT1—liver cancer	3.49e-06	1.27e-05	CbGpPWpGaD
